
Loading, please wait...

Loading, please wait...

Gautam Adani recently launched a landmark vision care in Bihar initiative to address rural health challenges. This ambitious project focuses on providing affordable treatment and building a sustainable healthcare ecosystem in the region. Consequently, the Adani Akhand Jyoti Foundation seeks to restore sight and dignity to underserved communities. Furthermore, the initiative targets the completion of 3.3 lakh eye surgeries annually. This effort will significantly reduce the burden of preventable blindness in the Hindi heartland.
The project establishes two primary facilities: the Adani Centre for Eye (ACE) and Adani Training in Ophthalmic Medicine (ATOM). Specifically, ACE handles complex surgical procedures and advanced treatments. Meanwhile, ATOM focuses on essential workforce development. It will train 1,000 eye health professionals, including optometrists and assistants, every year. Moreover, this dual approach ensures that infrastructure growth matches the availability of skilled personnel. Additionally, the group plans to establish a 200-bed hospital in the Bhagalpur district to serve eastern Bihar.
The Adani family has committed significant resources to this long-term mission. Initially, the project received Rs 150 crore for immediate development in Bihar. However, Gautam Adani later announced an additional personal commitment of Rs 500 crore to scale the mission nationwide. Consequently, the total investment outlay will exceed Rs 700 crore. This investment reflects a broader vision of nation-building through social service and healthcare excellence. Similarly, the foundation continues to support various rural outreach programs across eleven states in India.
Q1: What is the primary goal of the Adani Centre for Eye (ACE)?
ACE aims to provide advanced treatment and surgical facilities focused on affordable care and large-scale rural outreach in Bihar.
Q2: How many eye health professionals will be trained annually?
The initiative plans to train 1,000 eye health professionals every year through the Adani Training in Ophthalmic Medicine (ATOM) facility.
Q3: What is the total investment commitment for this vision care project?
The total investment outlay, including operational expenditure, is expected to exceed Rs 700 crore across its expansion phases.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Gautam Adani initiates a Rs 150 crore vision care project in Bihar to provide affordable eye surgeries and train 1,000 healthcare professionals annually....
5 months ago

A prospective multicenter cohort study demonstrates that baseline health-related quality of life, particularly physical functioning, independently predicts all-cause maintenance hemodialysis mortality. Assessing patient-reported outcomes provides vital prognostic value beyond standard biochemical markers.
Today

Delhi is undergoing a major healthcare overhaul with enhanced Ayushman Bharat insurance up to ₹10 lakh, increased MBBS and PG medical training seats, expanded primary network mandirs, new tertiary neuro-ICUs, and public-private reproductive technology initiatives to build a resilient, preventative healthcare model.
Today

Aon forecasts India's healthcare inflation will ease to 10.1% in 2027 from 11.5% in 2026. Despite moderation, healthcare expenses continue to outpace general inflation, propelled by non-communicable diseases, advanced medical therapeutics, and expanding utilization patterns across diverse patient populations.
Today

Non-union fractures occur in 2-5% of cases, causing significant disability and cost. Conservative modalities such as LIPUS, PEMF, and focused ESWT offer non-surgical healing options for defects up to 5-10 mm when adequate mechanical stability exists without infection.
Yesterday

Explore how novel oxygen-releasing PVA hydrogels prevent early post-transplant hypoxic damage in pancreatic beta cells, sustaining viability and insulin secretory function.
Today